alcohol-induced disorders
alcohol-induced disorders
Explore linked clinical trials. Standard reference: MONDO:002169970 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) | Chemically-Induced Disorders, Digestive System Diseases, alcohol-induced disorders, alcohol-related disorders, alcoholic hepatitis, alcoholic liver disease, hepatitis, liver disorder, substance-related disorder | Recruiting | Phase 3 | 2026-10-06 | NCT07428538 | |
| A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD) | Chemically-Induced Disorders, Digestive System Diseases, alcohol-induced disorders, alcohol-related disorders, alcoholic liver disease, liver disorder, substance-related disorder | Recruiting | Phase 2 | 2026-09-30 | NCT07791043 | |
| Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, substance-related disorder | Recruiting | Phase 2 | 2026-09-28 | NCT05832229 | |
| Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19 | Chemically-Induced Disorders, Digestive System Diseases, alcohol-induced disorders, alcohol-related disorders, alcoholic liver disease, liver disorder, substance-related disorder | Recruiting | Not applicable | 2026-09-25 | NCT04858412 | |
| Comparison of ALD, NASH, and Healthy Control Patients | Chemically-Induced Disorders, Digestive System Diseases, alcohol-induced disorders, alcohol-related disorders, alcoholic liver disease, liver disorder, substance-related disorder | Recruiting | Not stated | 2026-09-25 | NCT03224949 | |
| Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD) | Chemically-Induced Disorders, Digestive System Diseases, alcohol-induced disorders, alcohol-related disorders, alcoholic liver disease, liver disorder, substance-related disorder | Active, not recruiting | Not stated | 2026-09-25 | NCT03113929 | |
| HA35 Moderate Alcoholic Hepatitis (AH) Study | Chemically-Induced Disorders, Digestive System Diseases, alcohol-induced disorders, alcohol-related disorders, alcoholic hepatitis, alcoholic liver disease, hepatitis, liver disorder, substance-related disorder | Recruiting | Early phase 1 | 2026-09-24 | NCT05018481 | |
| Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis | Chemically-Induced Disorders, Digestive System Diseases, alcohol-induced disorders, alcohol-related disorders, alcoholic hepatitis, alcoholic liver disease, hepatitis, liver disorder, substance-related disorder | Recruiting | Not stated | 2026-09-24 | NCT04088370 | |
| Preventox - a Digital Intervention for Patients With Intoxications in Intensive Care | Alcohol-Induced Disorders, Nervous System, Chemically-Induced Disorders, alcohol withdrawal delirium, alcohol-induced disorders, alcohol-related disorders, nervous system disorder, poisoning, psychiatric disorder, substance withdrawal syndrome, substance-related disorder, toxic encephalopathy | Not yet recruiting | Not applicable | 2026-09-23 | NCT07819500 | |
| A-TANGO Phase 2 Study | Acute-On-Chronic Liver Failure, Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute liver failure, alcohol-induced disorders, alcohol-related disorders, alcoholic hepatitis, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, hepatitis, liver disorder, liver failure, substance-related disorder | Recruiting | Phase 2 | 2026-09-21 | NCT06890039 | |
| Long-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LC | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, substance-related disorder | Recruiting | Not stated | 2026-09-21 | NCT05093881 | |
| Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, substance-related disorder | Recruiting | Phase 3 | 2026-09-21 | NCT04689152 | |
| Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease | Chemically-Induced Disorders, Digestive System Diseases, alcohol-induced disorders, alcohol-related disorders, alcoholic hepatitis, alcoholic liver disease, hepatitis, liver disorder, substance-related disorder | Recruiting | Not stated | 2026-09-16 | NCT07060547 | |
| Families Moving Forward (FMF) Connect Pro for Mental Health Providers | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Urogenital Diseases, alcohol-induced disorders, alcohol-related disorders, fetal alcohol spectrum disorder, pregnancy disorder, substance-related disorder | Recruiting | Not applicable | 2026-09-10 | NCT05960461 | |
| The Synchrony Study: Examining Music Training for Children With FASD | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Urogenital Diseases, alcohol-induced disorders, alcohol-related disorders, fetal alcohol spectrum disorder, pregnancy disorder, substance-related disorder | Recruiting | Not applicable | 2026-08-14 | NCT06005181 | |
| Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Heart Decompensation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cardiovascular disorder, cirrhosis of liver, heart disorder, heart failure, liver disorder, metabolic dysfunction-associated steatotic liver disease, substance-related disorder | Recruiting | Not applicable | 2026-08-04 | NCT06814990 | |
| A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease | Chemically-Induced Disorders, Digestive System Diseases, alcohol-induced disorders, alcohol-related disorders, alcoholic liver disease, fatty liver disease, liver disorder, substance-related disorder | Recruiting | Phase 2 | 2026-08-03 | NCT06613698 | |
| Pomegranate Dietary Supplements in AUD and ALD | Alcohol Use Disorder, Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, psychiatric disorder, substance-related disorder | Not yet recruiting | Not stated | 2026-07-24 | NCT07678567 | |
| Long-term Sustainability of the Effects of Dog-Assisted Therapy in Children and Adolescents With Fetal Alcohol Spectrum Disorder: a 12-month Longitudinal Study | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Urogenital Diseases, alcohol-induced disorders, alcohol-related disorders, fetal alcohol spectrum disorder, fetal alcohol syndrome, pregnancy disorder, substance-related disorder | Active, not recruiting | Not applicable | 2026-07-21 | NCT07717190 | |
| Efficacy Of Bovine Colostrum In The Treatment Of Severe Alcohol-Associated Hepatitis: A Randomized Controlled Trial | Chemically-Induced Disorders, Digestive System Diseases, alcohol-induced disorders, alcohol-related disorders, alcoholic hepatitis, alcoholic liver disease, hepatitis, liver disorder, substance-related disorder | Active, not recruiting | Phase 3 | 2026-07-21 | NCT02473341 | |
| Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Urogenital Diseases, alcohol-induced disorders, alcohol-related disorders, attention deficit hyperactivity disorder, inattentive type, fetal alcohol spectrum disorder, neurodevelopmental disorder, oppositional defiant disorder, pregnancy disorder, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-07-16 | NCT06847165 | |
| RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Urogenital Diseases, alcohol-induced disorders, alcohol-related disorders, fetal alcohol spectrum disorder, fetal alcohol syndrome, pregnancy disorder, substance-related disorder | Recruiting | Phase 2 | 2026-07-09 | NCT04395196 | |
| Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Urogenital Diseases, alcohol-induced disorders, alcohol-related disorders, fetal alcohol spectrum disorder, pregnancy disorder, substance-related disorder | Active, not recruiting | Phase 2 | 2026-07-08 | NCT05108974 | |
| Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver disease, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, substance-related disorder | Recruiting | Not applicable | 2026-06-30 | NCT05699018 | |
| CARRII Native Intervention Optimization Trial | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Urogenital Diseases, alcohol-induced disorders, alcohol-related disorders, fetal alcohol spectrum disorder, pregnancy disorder, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-06-23 | NCT07547696 |